Back

HCM in the modern era: low mortality and predominantly predictable sudden cardiac death under systematic risk stratification

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: disease burden, risk stratification, and clinical outcomes Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Evangelia Karvouni

Hygeia Hospital, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Longitudinal burden of disease in hypertrophic cardiomyopathy: one-year follow-up of the AFFECT-HCM study
Miss R. Mangal (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Real-world clinical burden of obstructive hypertrophic cardiomyopathy: a nationwide study in france
Professor A. Hagege (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Simplified versus complete selvester QRS scoring system for scar assessment in hypertrophic cardiomyopathy patients
Doctor N. Charoenpoonsiri (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Continuous ambulatory ECG monitoring of up to 14 days increases detection of high-risk ventricular tachyarrhythmias compared with the first 48 hours in hypertrophic cardiomyopathy
Doctor M. Maron (Burlington, US)
Abstract Slides Video
Presentation thumbnail
Mavacamten improves functional status in obstructive hypertrophic cardiomyopathy without increasing serious adverse events: a systematic review and meta-analysis
Doctor I. Figueroa Baez (San Juan, PR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: disease burden, risk stratification, and clinical outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Evaluation of the hypothetical risk of sudden cardiac death in obstructive HCM patients treated with mavacamten using the HCM Risk-SCD score
29 August 2026
thumbnail
Congress Presentation
Sex differences in long-term arrhythmogenic and mortality outcomes in patients with hypertrophic cardiomyopathy: a 20-year longitudinal observational study
30 August 2026
thumbnail
Congress Presentation
The influence of genotype on the phenotype and prognosis of patients with hypertrophic cardiomyopathy
19 May 2025
thumbnail
Congress Presentation
Body mass index extremes association with worsened disease and clinical outcomes in patients with hypertrophic cardiomyopathy
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources